Dr. Michael Reardon and Dr. Yazan Daaboul Discuss: Insights From The Corevalve US Pivotal And SURTAVI Trials: Five-year Incidence, Timing And Predictors Of Hemodynamic Valve Deterioration Of Transcatheter And Surgical Aortic Bioprostheses April 4, 2022 Disclosures: TBA
Dr. Yutao Guo and Dr. Yazan Daaboul Discuss: A Report From The mAFA-II Trial Long-term Extension Cohort: Consumer-led Screening For Atrial Fibrillation April 3, 2022 Disclosures: TBA
Dr. Adriaan Voors and Dr. Arzu Kalayci Discuss: EMPULSE: Efficacy and Safety of Empagliflozin in Hospitalized Heart Failure Patients November 14, 2021 Disclosures: TBA
Dr. Tariq Ahmad and Dr. Arzu Kalayci Discuss: REVeAL-HF: Risk Evaluation and Its Impact on Clinical Decision Making and Outcomes in Heart Failure November 14, 2021 Disclosures: TBA
Dr. Susheel Kodali and Dr. Ajay Kirtane Discuss: TRISCEND: Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation November 6, 2021 Disclosures: TBA
Dr. Firas Zahr and Dr. C. Michael Gibson Discuss: Intrepid TMVR Early Feasibility: Thirty-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement November 6, 2021 Disclosures: TBA
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: TCT 2021 Daily Wrap-Up – November 6, 2021 November 6, 2021 Disclosures: TBA
Dr. Bruno Scheller and Dr. C. Michael Gibson Discuss: One-year Outcomes of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons Versus POBA in Coronary In-Stent Restenosis Lesions November 6, 2021 Disclosures: TBA
Dr. Wan Azman Wan Ahmad and Dr. C. Michael Gibson Discuss: A Randomized Trial of Sirolimus-coated Versus Paclitaxel-coated Balloons in De Novo Coronary Lesions November 6, 2021 Disclosures: TBA
Dr. Roberto Galea and Dr. C. Michael Gibson Discuss: SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure November 6, 2021 Disclosures: TBA
